Hanna GJ, Scarfo N, Shin KY, O'Neill A, et al. Elraglusib, a Glycogen Synthase Kinase 3beta Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma. Clin Cancer Res 2026;32:83-93.
PMID: 41065505